Savara Pharmaceuticals
SVRA
#6616
Rank
S$0.74 B
Marketcap
$4.35
Share price
-1.23%
Change (1 day)
-29.08%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -S$0.11 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$73.89 Million a decrease over its 2022 earnings that were of -S$51.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.11 Billion48.8%
2023 -S$73.89 Million43.38%
2022 -S$51.53 Million-11.31%
2021 -S$58.1 Million-13.3%
2020 -S$67.02 Million-36.53%
2019 -S$0.11 Billion13.76%
2018 -S$92.82 Million105.54%
2017 -S$45.16 Million34.11%
2016 -S$33.68 Million-37.43%
2015 -S$53.82 Million38.81%
2014 -S$38.77 Million33.62%
2013 -S$29.02 Million38.49%
2012 -S$20.96 Million24.59%
2011 -S$16.82 Million-36.5%
2010 -S$26.48 Million-3.14%
2009 -S$27.34 Million-23.28%
2008 -S$35.64 Million8.52%
2007 -S$32.84 Million-34.14%
2006 -S$49.87 Million184.43%
2005 -S$17.54 Million90.75%
2004 -S$9.2 Million190.35%
2003 -S$3.17 Million11.64%
2002 -S$2.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$24.53 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA